A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)

NCT00750334 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated to focus on comparable trial, CLOMDS02507

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: clofarabine
DRUG: clofarabine

Sponsor

Genzyme, a Sanofi Company